Association Between Elevated Total Homocysteine and Heart Failure Risk in the Multi-Ethnic Study of Atherosclerosis

Amy B Karger1, Sarah O Nomura1, Weihua Guan2

  • 1Department of Laboratory Medicine & Pathology University of Minnesota Minneapolis MN USA.

Insights

Elevated total homocysteine (tHcy) is linked to heart failure (HF) risk, particularly HF with preserved ejection fraction (HFpEF). The study highlights differing impacts of tHcy and dysglycemia on HF subtypes.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Epidemiology

Background:

  • Limited research links elevated total homocysteine (tHcy) to heart failure (HF) risk.
  • No studies have investigated if this association varies by HF subtype (HFpEF, HFrEF).

Purpose of the Study:

  • To examine the relationship between tHcy and the risk of overall HF, HFpEF, and HFrEF.
  • To assess if the impact of tHcy on HF risk differs by HF subtype.
  • To investigate the combined effects of elevated tHcy and dysglycemia on HF incidence.

Main Methods:

  • Utilized data from 6765 participants in the Multi-Ethnic Study of Atherosclerosis with baseline tHcy and HF data.
  • Employed Cox proportional hazards regression to calculate hazard ratios for tHcy and HF risk.
  • Stratified models by impaired fasting glucose/type 2 diabetes status to examine combined impacts.

Main Results:

  • Elevated tHcy (>12 micromol/L) was significantly associated with overall HF and HFpEF.
  • Individuals with both elevated tHcy and dysglycemia showed increased risk for overall HF and HFrEF, with a trend for HFpEF.
  • tHcy was a stronger contributor to HFpEF risk, while dysglycemia was more critical for HFrEF risk.

Conclusions:

  • Confirms the association between hyperhomocysteinemia and HF risk in a large, multi-ethnic cohort.
  • First study to show that tHcy's impact on HF risk differs by subtype.
  • tHcy appears to contribute more significantly to HFpEF risk than HFrEF risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K